Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer

NCT01174121 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

332

Enrollment

NIH

Sponsor class

Conditions

Metastatic Colorectal Cancer
Metastatic Pancreatic Cancer
Metastatic Ovarian Cancer
Metastatic Breast Carcinoma
Metastatic Endocrine Tumors/ Neuroendocrine Tumors

Interventions

DRUG: Pembrolizumab (Keytruda)
DRUG: Fludarabine
DRUG: Cyclophosphamide
DRUG: Aldesleukin
BIOLOGICAL: Young TIL

Sponsor

National Cancer Institute (NCI)